Guardant Health (GH) PT Raised to $200 at RBC Capital
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $177.92 +0.43%
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
RBC Capital analyst Dan Leonard raised the price target on Guardant Health (NASDAQ: GH) to $200.00 (from $185.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Greatland Resources Ltd (GGP:AU) PT Lowered to AUD13.50 at RBC Capital
- AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
